GAFA
GSK icon

Garton & Associates Financial Advisors’s GSK GSK Stock Holding History

Garton & Associates Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-175
Closed -$8.58K – 360
2025
Q4 		$8.58K Buy
+175
New +$8.16K ﹤0.01% 870

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Garton & Associates Financial Advisors's GSK Position: Q1 2026 in Review

Garton & Associates Financial Advisors sold out of GSK (GSK) in Q1 2026, closing a stake of 175 shares — an estimated $8.58K sold.

Garton & Associates Financial Advisors first reported a position in GSK in Q4 2025 and held it in 1 quarter. The position peaked at $8.58K in Q4 2025. 1,035 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Garton & Associates Financial Advisors reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
  • Garton & Associates Financial Advisors sold 175 GSK shares in Q1 2026, an estimated $8.58K.
  • Garton & Associates Financial Advisors first reported a position in GSK in Q4 2025 and held it in 1 quarter.
  • Garton & Associates Financial Advisors's GSK position peaked at $8.58K in Q4 2025.
  • 1,035 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Garton & Associates Financial Advisors's 13F filing for Q1 2026, filed 11 May 2026.